Division of Infectious Diseases, Penn State Milton S. Hershey Medical Center, BMR Bldg, Room C6860, Hershey, PA 17033, United States.
Division of Infectious Diseases, Penn State Milton S. Hershey Medical Center, BMR Bldg, Room C6860, Hershey, PA 17033, United States.
J Infect. 2020 Feb;80(2):197-203. doi: 10.1016/j.jinf.2019.12.007. Epub 2019 Dec 19.
In multiple countries, endovascular/disseminated Mycobacterium chimaera infections have occurred in post-cardiac surgery patients in association with contaminated, widely-distributed cardiac bypass heater-cooler devices. To contribute to long-term characterization of this recently recognized infection, we describe the clinical course of 28 patients with 3-7 years of follow-up for survivors.
Identified at five hospitals in the United States 2010-2016, post-cardiac surgery patients in the cohort had growth of Mycobacterium avium complex (MAC)/M. chimaera from a sterile site or surgical wound, or a clinically compatible febrile illness with granulomatous inflammation on biopsy. Case follow-up was conducted in May 2019.
Of 28 patients, infection appeared to be localized to the sternum in four patients. Among 18 with endovascular/disseminated infection who received combination anti-mycobacterial treatment and had sufficient follow-up, 39% appeared to have controlled infection (>12 months), 56% died, and one patient is alive with relapsed bacteremia. While the number of patients is small and interpretation is limited, four (67%) of six patients who had cardiac prosthesis removal/replacement appeared to have controlled infection compared to three (25%) of 12 with retained cardiac prosthesis (p >0.14; Fisher's exact test).
Given poor response to treatment and potential for delayed relapses, post-cardiac surgery M. chimaera infection warrants aggressive treatment and long-term monitoring.
在多个国家,心脏手术后患者发生了与污染、广泛分布的心脏旁路热交换器设备有关的血管内/播散性鸟分枝杆菌复合体(MAC)/M. chimaera 感染。为了对这种最近发现的感染进行长期特征描述,我们描述了 28 名幸存者的 3-7 年随访的临床病程。
2010 年至 2016 年在美国的五家医院中确定了该队列中的心脏手术后患者,他们从无菌部位或手术伤口培养出 MAC/M. chimaera,或有发热伴活检显示肉芽肿性炎症的临床相符的发热性疾病。在 2019 年 5 月进行了病例随访。
28 名患者中,4 名患者的感染似乎局限于胸骨。在 18 名接受联合抗分枝杆菌治疗且随访时间足够的血管内/播散性感染患者中,39%的患者感染似乎得到了控制(>12 个月),56%的患者死亡,1 名患者复发菌血症后仍存活。虽然患者数量较少且解释受到限制,但与 12 名保留心脏假体的患者相比,6 名接受心脏假体取出/更换的患者中有 4 名(67%)似乎控制了感染(p >0.14;Fisher 确切检验)。
鉴于治疗反应不佳和潜在的延迟复发,心脏手术后 M. chimaera 感染需要积极治疗和长期监测。